Results 51 to 60 of about 4,036 (167)

Contemporary Analysis of VTE Risk After HPB Surgery: 2517 Consecutive Patients Treated With Extended Chemoprophylaxis

World Journal of Surgery, Volume 50, Issue 6, Page 1663-1665, June 2026.
Independent predictors of Venous Thromboembolism (VTE) within the first 45 post‐operative days on multivariate analyses.
Anish J. Jain, Esther N. Dekker, Laura Prakash, Elsa M. Arvide, Yi‐Ju Chiang, Rebecca A. Snyder, Matthew H. G. Katz, Ching‐Wei D. Tzeng   +7 more
wiley   +1 more source

Surgical approach on Reccurent Retroperitoneal Liposarcoma with Involvement of Surrounding Organs

Albanian Journal of Trauma and Emergency Surgery, 2019
Background: Retroperitoneal sarcomas are neoplasm that are only 0,3-3% of all solid tumors. Liposarcomas is most freguent soft tissue sarcomas in adults. Symptoms would only be detected if the liposarcoma presses on the surrounding organs.
Rexhep Selmani, Zoran Karadzov, Goran Begovic, Qemal Rushiti, Nenad Vrgovic, Dejan Gogovski, Darko Domazetovski   +6 more
doaj   +1 more source

Neoadjuvant chemotherapy for soft‐tissue sarcoma of the extremities: A post‐hoc Sarculator‐based risk analysis of the EORTC 62961–ESHO 95 randomized trial

Cancer, Volume 132, Issue 9, 1 May 2026.
Abstract Background In the EORTC 62961–ESHO 95 randomized trial (European Organization for Research and Treatment 62961–European Society of Hyperthermia Oncology 95; ClinicalTrials.gov identifier NCT00003052), neoadjuvant chemotherapy (NAC) combined with regional hyperthermia (RHT) improved survival in patients with soft tissue sarcoma (tumor size >5 ...
Markus Albertsmeier, Valeria Milani, Lars H. Lindner, Gabriele Tinè, Sandro Pasquali, Dario Callegaro, Alessandro Gronchi, Hans‐Roland Dürr, Alexander Klein, Dorit Di Gioia, Sultan Abdel‐Rahman, Michael Schmidt, Jens Werner, Michael von Bergwelt‐Baildon, Rosalba Miceli, Rolf Issels   +15 more
wiley   +1 more source

A giant retroperitoneal liposarcoma encasing vital organs: A case report

Journal of the Pakistan Medical Association
Liposarcoma is the most common primary malignant tumour of the retroperitoneum. As the retroperitoneum is a large space, these tumours can grow significantly before diagnosis.
Adeena Azam, Amna Faheem Mufti, Faizan Masood, Hafiz Usman Azeem   +3 more
doaj   +1 more source

Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma

Clinical and Translational Medicine, Volume 16, Issue 5, May 2026.
Retroperitoneal sarcoma cells can secrete prolactin into the bloodstream, inducing hyperprolactinaemia, which subsequently triggers metabolic reprogramming, such as glucose metabolism. SOX4 can function as a transcription factor that facilitates PRL transcription.
Fu'an Xie, Lingwei Gu, Kunrong Yang, Shuai Wang, Mengmeng Xiao, Guangting Yan, Quan Zhang, Rubing Liang, Aobo Zhuang, Zhe Xi, Yujia Niu, Yanhua Chen, Xiaogang Xia, Linlin Qu, Bin Zhao, Weibing Li, Ting Wu, Chundong Yu, Chenghua Luo, Houzhao Wang, Lanlan Lian, Wengang Li   +21 more
wiley   +1 more source

Negative Pressure Wound Therapy as a Key Strategy in the Management of Severe Diabetic Foot Ulcers in Septic Frail Patients: A Case Series

International Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT Diabetes mellitus represents a major global health challenge, with over 537 million adults currently affected worldwide. Among its complications, diabetic foot ulcers remain a leading cause of morbidity, hospitalization and amputation, imposing a significant socioeconomic burden.
Maria Ignacy Pirski, Silvia Malerba, Luigi Marano, Martyna Kur, Jaroslaw Skokowski, Maciej Świerblewski   +5 more
wiley   +1 more source

Giant Retroperitoneal Liposarcoma: A Case Report

Case Reports in Oncological Medicine, 2012
Soft tissue sarcomas represent less than 1% of all human neoplasms. One-third of malignant tumors that arise in the retroperitoneum are sarcomas and liposarcoma is the most common retroperitoneal sarcoma.
Chavan Shahaji, Parasnis Amit, Punia Prashant, Tekade Sachin   +3 more
doaj   +1 more source

Optimizing Systemic Therapy for Advanced Sarcomas: Outcomes With Gemcitabine, Docetaxel, Cisplatin, and Everolimus in a Retrospective Single‐Center Study

Cancer Medicine, Volume 15, Issue 4, April 2026.
Late‐line gemcitabine, docetaxel, cisplatin, and everolimus yield a 45.5% objective response rate and prolonged survival in selected advanced sarcoma subtypes. Prognostic stratification was enhanced by ECOG performance status and lymphocyte‐to‐monocyte ratio, highlighting their potential role in treatment individualization. ABSTRACT Background Advanced
Wen‐Chi Wu, I‐Wei Ho, San‐Chi Chen, Paul Chih‐Hsueh Chen, Po‐Kuei Wu, Chao‐Ming Chen, Hung‐Ta Wu, Chung‐Jung Lin, Ta‐Chung Chao, Chueh‐Chuan Yen   +9 more
wiley   +1 more source

Robotic retroperitoneal surgery in a uro‐oncology specialised centre: Translating RPLND expertise from testicular cancer to non‐genitourinary retroperitoneal tumour resection

BJUI Compass, Volume 7, Issue 3, March 2026.
Abstract Objective The aim of this study is to evaluate the feasibility and perioperative outcomes of robotic‐assisted resection of selected non‐genitourinary retroperitoneal tumours (RA‐RTR) performed by urologists with established experience in robotic retroperitoneal lymph node dissection (RA‐RPLND) within a specialised centre.
Alberto Costa Silva, Jeremy Oates, Aziz Gulamhusein   +2 more
wiley   +1 more source

Huge retroperitoneal liposarcoma.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2011
Liposarcoma are one of the common soft tissue sarcomas of adulthood which are remarkable because of their frequently large size. We report a case with an extremely large well-differentiated retroperitoneal liposarcoma that weighted 32 kilograms. The patient had relapse about one year later and two recurrent tumors were successfully excised.
Mohammad Reza Akhoondinasab, Mahmoud Omranifard   +1 more
openaire   +2 more sources